慢性肾脏病中心力衰竭事件的预测:CRIC研究
在2147例无心力衰竭的慢性肾脏病(CKD)患者中,比较ARIC临床方程、超声心动图变量及心脏生物标志物对10年心力衰竭住院的预测能力。ARIC模型C指数为0.68,超声变量为0.70,NT-proBNP联合hsTnT为0.73(较ARIC模型显著更优,P=0.004),三者联合模型C指数为0.77。
要点
- 在CKD人群中,ARIC心力衰竭预测模型10年区分度仅为中等(C指数0.68)。
- NT-proBNP联合hsTnT的区分度优于ARIC模型(C指数0.73 vs 0.68,P=0.004)。
- 联合临床变量、生物标志物和超声变量的模型C指数达0.77。
核心结论
- ARIC心力衰竭预测模型对CKD成人10年心力衰竭风险的区分度仅为中等。
- NT-proBNP和hsTnT的区分度优于ARIC模型,且至少与超声心动图变量模型相当。
- 需要针对CKD成人定制的心力衰竭临床预测模型;在此之前,检测NT-proBNP和hsTnT可能是一种低负担的预测方法,因其提供中等区分度。
研究设计与样本
- 研究纳入2147例无既往心力衰竭的慢性肾功能不全队列(CRIC)参与者,具有完整临床、心脏生物标志物(NT-proBNP和hsTnT)及超声心动图数据(左心室质量[LVM]和左心室射血分数[LVEF])。
- 采用Fine和Gray模型比较11变量ARIC心力衰竭预测方程与LVM、LVEF、hsTnT、NT-proBNP对10年心力衰竭住院风险的预测区分度。
- 分别评估射血分数保留(LVEF≥50%)和射血分数降低(LVEF<50%)的心力衰竭预测。
- 使用10折交叉验证的内部有效C指数评估区分度。
主要发现
- 参与者平均(SD)年龄59(11)岁,53%为男性,43%为黑人,平均(SD)eGFR为44(16)ml/min/1.73 m²。
- 中位(四分位距)随访10.0(5.7-10.0)年期间,共发生324例心力衰竭住院。
- 含临床变量的ARIC心力衰竭模型C指数为0.68;超声心动图变量预测心力衰竭的C指数为0.70,与已发表的ARIC心力衰竭模型相当。
- NT-proBNP和hsTnT联合的C指数为0.73,区分度显著更优(P=0.004)。
- 包含心脏生物标志物、超声心动图变量和临床变量的模型C指数为0.77。
关键数值与推荐
- ARIC心力衰竭模型(临床变量)C指数0.68;超声心动图变量C指数0.70;NT-proBNP联合hsTnT C指数0.73(较ARIC模型P=0.004);联合模型C指数0.77。
- 射血分数保留(LVEF≥50%)与射血分数降低(LVEF<50%)的心力衰竭预测区分度比较:多数模型后者更高。
临床怎么用
- 作者认为,在针对CKD成人的定制模型可用之前,检测NT-proBNP和hsTnT可能是一种低负担的预测心力衰竭的方法,因其提供中等区分度。
- 原文未据此给出其他推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Heart failure (HF) is common in chronic kidney disease (CKD); identifying patients with CKD at high risk for HF may guide clinical care. We assessed the prognostic value of cardiac biomarkers and echocardiographic variables for 10-year HF prediction compared with a published clinical HF prediction equation in a cohort of participants with CKD. METHODS: We studied 2147 Chronic Renal Insufficiency Cohort (CRIC) participants without prior HF with complete clinical, cardiac biomarker (N-terminal brain natriuretic peptide [NT-proBNP] and high sensitivity troponin-T [hsTnT]), and echocardiographic data (left ventricular mass [LVM] and left ventricular ejection fraction [LVEF] data). We compared the discrimination of the 11-variable Atherosclerosis Risk in Communities (ARIC) HF prediction equation with LVM, LVEF, hsTnT, and NT-proBNP to predict 10-year risk of hospitalization for HF using a Fine and Gray modeling approach. We separately evaluated prediction of HF with preserved and reduced LVEF (LVEF ≥50% and <50%, respectively). We assessed discrimination with internally valid C-indices using 10-fold cross-validation. RESULTS: Participants' mean (SD) age was 59 (11) years, 53% were men, 43% were Black, and mean (SD) estimated glomerular filtration rate (eGFR) was 44 (16) ml/min per 1.73 m2. A total of 324 incident HF hospitalizations occurred during median (interquartile range) 10.0 (5.7-10.0) years of follow-up. The ARIC HF model with clinical variables had a C-index of 0.68. Echocardiographic variables predicted HF (C-index 0.70) comparably to the published ARIC HF model, while NT-proBNP and hsTnT together (C-index 0.73) had significantly better discrimination (P = 0.004). A model including cardiac biomarkers, echocardiographic variables, and clinical variables had a C-index of 0.77. Discrimination of HF with preserved LVEF was lower than for HF with reduced LVEF for most models. CONCLUSION: The ARIC HF prediction model for 10-year HF risk had modest discrimination among adults with CKD. NT-proBNP and hsTnT discriminated better than the ARIC HF model and at least as well as a model with echocardiographic variables. HF clinical prediction models tailored to adults with CKD are needed. Until then, measurement of NT-proBNP and hsTnT may be a low-burden approach to predicting HF in this population, as they offer moderate discrimination.
引用
- Zelnick LR, Shlipak MG, Soliman EZ, et al. Prediction of Incident Heart Failure in CKD: The CRIC Study. Kidney Int Rep. 2022. PMID: 35497796. doi:10.1016/j.ekir.2022.01.1067
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。